MedicaidCoverageMedium impact
BT202165: IHCP pharmacy benefits resumes pre-COVID-19 policies
Indiana Medicaid (IHCP)·IN · Pulmonology, Family Medicine, Internal Medicine +2 more·Pharmacy
Effective date
Sep 3, 2021
We identified it
Jun 19, 2026
Summary
Indiana Health Coverage Programs (IHCP) is resuming pre-COVID-19 pharmacy policies effective September 3, 2021, including preferred status requirements for short-acting beta agonists like albuterol inhalers and reverting to standard 90-day maintenance drug supply processes. Patient signature requirements for pharmacy pickups already resumed August 1, 2021, but copayment suspensions remain in effect.
Action Required
By September 3, 2021: Billing and pharmacy staff must ensure patients with asthma/COPD have documentation of initial trial with preferred MDI (albuterol) before prescribing non-preferred inhalers to avoid coverage issues. Update patient counseling processes to inform members that 90-day maintenance drug supplies will revert to pre-COVID policies. Verify patient signature collection procedures are in place for pharmacy deliveries and pickups as required since August 1, 2021.